Search

Your search keyword '"Postadzhiyan A"' showing total 268 results

Search Constraints

Start Over You searched for: Author "Postadzhiyan A" Remove constraint Author: "Postadzhiyan A"
268 results on '"Postadzhiyan A"'

Search Results

1. 2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP): Optimal Lipid-Lowering Management in ACS Patients

2. Management of High and Very High-Risk Subjects with Familial Hypercholesterolemia: Results from an Observational Study in Bulgaria

4. Effect of conventional and more aggressive rosuvastatin treatment on markers of endothelial activation

6. Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study

7. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

8. Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP).

9. Long term effect of renal denervation on 24 hour abpm blood pressure variability and blood pressure load parameters

10. Opportunistic screening for hypertension in the general population in Bulgaria: international society of hypertension may measurement month campaign

11. Practical significance of individual blood pressure trajectories

12. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

13. Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network

14. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

16. Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)

17. Editorial

21. Periprocedural hemodynamic assessment of percutaneous balloon mitral valvuloplasty

22. Distal radial access. Occlussion of the radial artery after percutaneus coronary intervention with radial access

23. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

24. Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases – A position paper from the International Lipid Expert Panel (ILEP)

25. The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP)

27. Statin therapy in athletes and patients performing regular intense exercise – Position paper from the International Lipid Expert Panel (ILEP)

28. Blood pressure measurement and assessment of arterial structure and function:an expert group position paper

29. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

30. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

31. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

32. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

39. GPs' View on Barriers to Patients with Erectile Dysfunction: A Bulgarian Cross-sectional Study

42. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

43. Evolocumab is initiated in Central and Eastern Europe at Much Higher LDL-C Levels than Recommended in Guidelines: Results from the Observational HEYMANS Study

44. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

45. sj-docx-1-cpt-10.1177_10742484231172847 - Supplemental material for Evolocumab is Initiated in Central and Eastern Europe at Much Higher LDL-C Levels Than Recommended in Guidelines: Results from the Observational HEYMANS Study

46. Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network

47. Evolocumab is Initiated in Central and Eastern Europe at Much Higher LDL-C Levels Than Recommended in Guidelines: Results from the Observational HEYMANS Study

50. May Measurement Month 2021: an analysis of blood pressure screening results from Bulgaria

Catalog

Books, media, physical & digital resources